0

Tamibarotene

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP94497515
CAS94497-51-5
Structure
MDL NumberMFCD00866188
Molecular Weight351.44
InChI KeyMUTNCGKQJGXKEM-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: ≥10 mg/mL
Assay≥98% (HPLC)
Colorwhite to off-white
Formpowder
Size5MG, 25MG
Storage Conditionsroom temp
1

[State-of-the-art Treatment of Acute Promyelocytic Leukemia]

Toru Kiguchi

Rinsho Ketsueki. 2018;59(10):2007-2018.

PMID: 30305503

1

Identification of the Novel Deletion-Type PML-RARA Mutation Associated With the Retinoic Acid Resistance in Acute Promyelocytic Leukemia

Hikaru Hattori, Yuichi Ishikawa, Naomi Kawashima, Akimi Akashi, Yohei Yamaguchi, Yasuhiko Harada, Daiki Hirano, Yoshiya Adachi, Kotaro Miyao, Yoko Ushijima, Seitaro Terakura, Tetsuya Nishida, Tadashi Matsushita, etc.

PLoS One. 2018 Oct 5;13(10):e0204850.

PMID: 30289902

1

Superenhancer Analysis Defines Novel Epigenomic Subtypes of Non-APL AML, Including an RARα Dependency Targetable by SY-1425, a Potent and Selective RARα Agonist

Michael R McKeown, M Ryan Corces, Matthew L Eaton, Chris Fiore, Emily Lee, Jeremy T Lopez, Mei Wei Chen, Darren Smith, Steven M Chan, Julie L Koenig, Kathryn Austgen, Matthew G Guenther, David A Orlando, etc.

Cancer Discov. 2017 Oct;7(10):1136-1153.

PMID: 28729405

1

Tamibarotene

Ishido Miwako, Hiroyuki Kagechika

Drugs Today (Barc). 2007 Aug;43(8):563-8.

PMID: 17925887

1

Tamibarotene Maintenance Improved Relapse-Free Survival of Acute Promyelocytic Leukemia: A Final Result of Prospective, Randomized, JALSG-APL204 Study

Akihiro Takeshita, Norio Asou, Yoshiko Atsuta, Toru Sakura, Yasunori Ueda, Masashi Sawa, Nobuaki Dobashi, Yasuhiro Taniguchi, Rikio Suzuki, Masaru Nakagawa, Shigehisa Tamaki, Maki Hagihara, Katsumichi Fujimaki, etc.

Leukemia. 2019 Feb;33(2):358-370.

PMID: 30093681

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode